arGEN-X News
Most Popular arGEN-X Story
arGEN-X gins $13.6M in new funds for mAB work
The Dutch antibody developer arGEN-X has garnered $13.6 million in a Series A, which will be used to develop its antibody platform and create a slate of mAb candidates for development. The deal was Read more...
Latest Headlines
- December 1, 2011
- September 10, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
